SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-21-002093
Filing Date
2021-03-01
Accepted
2021-03-01 09:13:38
Documents
79
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cycc-20201231x10k.htm 10-K 1596215
2 EX-4.10 cycc-20201231ex4109d6cee.htm EX-4.10 160012
3 EX-23.1 cycc-20201231ex231e57d24.htm EX-23.1 2710
4 EX-31.1 cycc-20201231ex31190e56b.htm EX-31.1 12611
5 EX-31.2 cycc-20201231ex3122657f9.htm EX-31.2 12716
6 EX-32.1 cycc-20201231ex321c93409.htm EX-32.1 6405
7 EX-32.2 cycc-20201231ex322c58ca0.htm EX-32.2 6497
  Complete submission text file 0001558370-21-002093.txt   7266565

Data Files

Seq Description Document Type Size
8 EX-101.INS cycc-20201231.xml EX-101.INS 1519763
9 EX-101.SCH cycc-20201231.xsd EX-101.SCH 55170
10 EX-101.CAL cycc-20201231_cal.xml EX-101.CAL 55675
11 EX-101.DEF cycc-20201231_def.xml EX-101.DEF 208569
12 EX-101.LAB cycc-20201231_lab.xml EX-101.LAB 466315
13 EX-101.PRE cycc-20201231_pre.xml EX-101.PRE 388048
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50626 | Film No.: 21694349
SIC: 2834 Pharmaceutical Preparations